Showing 581 - 600 results of 69,560 for search '(( a ((we decrease) OR (nn decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.92s Refine Results
  1. 581
  2. 582
  3. 583

    <i>Trans ε</i> viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model by Martial Caillaud (6383672)

    Published 2019
    “…Here, effects of this stilbenoid were evaluated in transgenic APPswePS1dE9 mice. We report that <i>trans ε</i>-viniferin could go through the blood brain barrier, reduces size and density of amyloid deposits and decreases reactivity of astrocytes and microglia, after a weekly intraperitoneal injection at 10 mg/kg from 3 to 6 months of age.…”
  4. 584
  5. 585
  6. 586
  7. 587
  8. 588

    The effect of amiloride in decreasing albuminuria in patients with diabetic kidney diseases: a prospective, crossover, open-label study by Ruizhao Li (417128)

    Published 2021
    “…However, there is still a lack of specific treatment for DKD.</p> <p>We conducted a prospective, crossover, open-label study to investigate the effect of amiloride in patients with DKD. …”
  9. 589
  10. 590
  11. 591
  12. 592
  13. 593
  14. 594
  15. 595
  16. 596
  17. 597

    LSPC treatment decreases neuropathology in prion-infected mice. by Heather Bender (363996)

    Published 2019
    “…<p>Immunohistochemistry (IHC) of brain sections through the (A) cerebellum and (B) hippocampus in infected and uninfected mice reveal that (A) while we observed no difference in cerebellar PrP<sup>Res</sup> accumulation among infected untreated, non-responder or responder mice, both GFAP stain intensity, a measure of astrogliosis, and vacuolation, a hallmark of prion-mediated neurodegeneration, were significantly decreased in LSPC responder mice. …”
  18. 598
  19. 599
  20. 600